文献速递呼吸道感染肺栓塞与肺血管病呼吸危重症与机械通气

炎症与血栓之间:COVID-19中的内皮细胞

Between inflammation and thrombosis: endothelial cells in COVID-19.
PubMed 文献 · Eur Respir J · 2021-09-09

该文分析COVID-19患者肺组织与血浆中多种内皮标志物(CD31、VEGFR-2、ICAM-1、VCAM-1、E-选择素、P-选择素、vWF),指出肺内皮在局部及全身COVID-19病理中起重要作用;内皮功能障碍标志物与不良预后相关,并涉及肺水肿、血管内血栓形成和ARDS。

要点

  • COVID-19肺组织与循环中多种内皮标志物升高,支持肺内皮在局部和全身病理中的作用。
  • 内皮功能障碍与内皮完整性改变的标志物是SARS-CoV-2感染不良预后的重要预测因素。
  • 这些标志物与肺水肿、血管内血栓形成和ARDS相关。

核心结论

  • 肺内皮在COVID-19局部和全身病理中起重要作用。
  • 内皮功能障碍和内皮完整性改变的标志物是SARS-CoV-2感染不良预后的重要预测因素。

研究设计与样本

  • 分析COVID-19患者肺组织和血浆样本中多种血管标志物。

主要发现

  • 肺组织和循环中CD31、VEGFR-2、ICAM-1、VCAM-1、E-选择素、P-选择素和vWF水平升高。
  • 内皮功能障碍标志物与肺水肿、血管内血栓形成和ARDS相关。

关键数值与推荐

  • 分析的标志物包括E-选择素、ICAM-1、VCAM-1、CD31、VEGFR-2、P-选择素和vWF。

局限性

  • 导致COVID-19肺血管病变的确切机制仍不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Elevated levels of several endothelial markers, including CD31, VEGFR-2, ICAM-1, VCAM-1, E-selectin, P-selectin and vWF, in lung tissue and circulation support an important role of the pulmonary endothelium in local and systemic COVID-19 pathology https://bit.ly/3eQObIR Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current coronavirus disease (COVID-19) pandemic [1]. Over recent months, a plethora of novel research articles has been published, dealing with multiple aspects and manifestations of the disease. Increasing evidence points to a central role of endothelial cells in SARS-CoV-2 infection [2–5]. Early studies have already indicated increased expression of vascular and inflammatory factors (such as vascular cell adhesion molecule (VCAM)-1, interleukin (IL)-8 or monocyte-chemoattractant protein (MCP)-1) in COVID-19 lung tissue [2]. Such markers of endothelial dysfunction and altered endothelial cell integrity are important predictors of a poor outcome in SARS-CoV-2 infections [6], and they are associated with pulmonary oedema, intravascular thrombosis and acute respiratory distress syndrome (ARDS). The pulmonary endothelium is crucial for regulation of vascular tone, inflammatory responses, coagulation/fibrinolysis and maintenance of vascular homeostasis and permeability. Disturbances of these tightly regulated processes may directly contribute to morbidity and mortality. However, the exact mechanisms leading to pulmonary vasculopathy in COVID-19 are still unclear. Here, we provide an analysis of several important vascular markers implicated in the inflammatory response (E-selectin, intercellular cell adhesion molecule (ICAM)-1, VCAM-1), maintenance of microvascular integrity (CD31, vascular endothelial growth factor receptor (VEGFR)-2), platelet activation and coagulation (P-selectin, von Willebrand factor (vWF)) in lung tissue and plasma samples of COVID-19 patients.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Birnhuber A, Fließer E, Gorkiewicz G, et al. Between inflammation and thrombosis: endothelial cells in COVID-19. Eur Respir J. 2021. PMID: 33958433. doi:10.1183/13993003.00377-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。